News

Mitchel Berger, MD, and Jeff Bluestone, PhD, have been named to a Blue Ribbon Panel of scientific experts, cancer leaders and patient advocates that will help to guide the National Cancer Moonshot Initiative. The UC San Francisco faculty members will help to inform the scientific direction and goals

Three researchers from the UCSF Helen Diller Family Comprehensive Cancer Center have received the NCI Outstanding Investigator Award in 2015: Thea D. Tlsty, PhD, Frank McCormick, PhD, FRS, DSc (Hon), and Markus Müschen, MD, PhD. NCI’s Outstanding Investigator Award supports accomplished leaders in

UC San Francisco received more than $560.4 million in highly competitive funding from the National Institutes of Health in 2015 to advance our research across our schools of dentistry, medicine, nursing, pharmacy and the Graduate Division. Return to the main story » Behind each grant and contract

Eleni Linos, MD, MPH, DrPH, and Stephen Francis, MS, PhD, have been awarded the first UCSF Cancer Center Impact Grants, to pursue high-risk, high-reward research projects that would’ve been unlikely to be funded through conventional mechanisms. The grants – each $250,000 – were announced following a

UC San Francisco today announced the establishment of the Quantitative Biosciences Institute (QBI). The mission of QBI, located on the UCSF Mission Bay health sciences campus, is to drive forward the application of computation, mathematics, and statistics toward a deeper understanding of complex

Scientists at UC San Francisco have been able to directly observe, for the first time, how invasive cancer cells create a beachhead as they migrate to the lung in a mouse model of metastatic cancer. What they saw was utterly surprising: early “pioneer” cancer cells that lodge in the lung generally

The most intractable common form of breast cancer might in most cases be treatable by drugs that target fat metabolism, according to UC San Francisco researchers who discovered the tumors’ frequent dependence on fat as an energy source, and then successfully treated human breast tumors that they